GENOME RESEARCH LIMITED
Company Information
- Company Number
- 02742969
- Registered Address
- Wellcome Sanger Institute Wellcome Genome Campus, Hinxton, Saffron Walden, England, CB10 1SA
- Status
- Active
- Employee Count
- Coming Soon
- Turnover
- Coming Soon
- EBITDA
- Coming Soon
Additional Details
- Company Type
- Private company limited by guarantee without share capital
- Incorporated On
- 20 August 1992
- Nature of Business
- 72110 - Research and experimental development on biotechnology
- Industries
- Coming Soon
- Region
- East of England
Time to Pay
Payment Timeline
Payment Features
Company Review
Trend Analysis
GENOME RESEARCH LIMITED consistently demonstrates prompt payment behavior, with an average payment time of 21 days. A significant 89% of invoices are settled within 30 days, indicating a strong trend towards timely fulfillment of payment obligations.
Volatility Analysis
Payment reliability is high, with excellent predictability as 89% of payments are processed within standard terms. Although 11% of payments are late, the very low proportion of invoices extending beyond 60 days (1%) suggests minimal payment volatility and generally stable performance.
Summary Analysis
Overall, GENOME RESEARCH LIMITED presents a highly favorable payment risk profile, making it a reliable partner for suppliers. While 11% of payments may be slightly delayed, the low overall late rate and rare extreme delays suggest that standard credit terms are appropriate, with minor attention to prompt follow-up for the small fraction that might be overdue.
Performance Reports History
| Reporting Period | Filing Date | Average Time to Pay (days) | Paid within 30 days | Paid 31-60 days | Paid after 60 days | Not Paid within Terms |
|---|---|---|---|---|---|---|
| 01 Apr 2025 - 30 Sept 2025 | 27 Oct 2025 | 21 | 89% | 10% | 1% | 11% |
| 01 Oct 2024 - 31 Mar 2025 | 07 May 2025 | 21 | 90% | 9% | 1% | 10% |
| 01 Apr 2024 - 30 Sept 2024 | 30 Oct 2024 | 21 | 89% | 10% | 1% | 1% |
| 01 Oct 2023 - 31 Mar 2024 | 30 Apr 2024 | 22 | 90% | 9% | 1% | 30% |
| 01 Apr 2023 - 30 Sept 2023 | 20 Nov 2023 | 24 | 82% | 16% | 2% | 30% |
| 01 Oct 2022 - 31 Mar 2023 | 18 Apr 2023 | 23 | 82% | 16% | 2% | 33% |
| 01 Apr 2022 - 30 Sept 2022 | 27 Oct 2022 | 28 | 79% | 18% | 3% | 35% |
| 01 Oct 2021 - 31 Mar 2022 | 27 Apr 2022 | 32 | 68% | 28% | 4% | 56% |
| 01 Apr 2021 - 30 Sept 2021 | 10 Nov 2021 | 26 | 79% | 18% | 3% | 0% |
| 01 Oct 2020 - 31 Mar 2021 | 19 Apr 2021 | 25 | 77% | 21% | 2% | 4% |
| 01 Apr 2020 - 30 Sept 2020 | 29 Oct 2020 | 20 | 87% | 10% | 3% | 8% |
| 01 Oct 2019 - 31 Mar 2020 | 23 Apr 2020 | 22 | 78% | 21% | 1% | 1% |
| 01 Apr 2019 - 30 Sept 2019 | 28 Oct 2019 | 19 | 91% | 7% | 2% | 12% |
| 01 Oct 2018 - 31 Mar 2019 | 30 Apr 2019 | 14 | 96% | 3% | 1% | 5% |
| 01 Apr 2018 - 30 Sept 2018 | 23 Oct 2018 | 13 | 96% | 3% | 1% | 0% |
| 01 Oct 2017 - 31 Mar 2018 | 23 Apr 2018 | 18 | 91% | 8% | 2% | 1% |
Payment Time Trends
Payment Distribution Trends
Invoice Payment Practices
This information is as reported by the business, and responses are in their own words.
Payment Terms
Standard payment terms
Genome Research Limited’s (“GRL”) standard payment terms are 30 days after receipt of invoice subject to goods having been delivered to the Company’s satisfaction
Were there any changes to the standard payment terms in the reporting period?
No information available
Any other information about payment terms
No additional information
Maximum contractual payment period agreed
30
Dispute Resolution Process
GRL attempt in good faith to resolve any dispute promptly through negotiations between representatives of the supplier and GRL staff who have appropriate authority
Other Payment Information
Has this business signed up to a code of conduct or standards on payment practices?
For example, signatories to The Prompt Payment Code must commit to paying 95% of their invoices within 60 days.
❌
Does this business offer e-invoicing in relation to qualifying contracts?
This is where suppliers can electronically submit and track invoices. It's not just allowing suppliers to email them an invoice.
❌
Does this business offer supply chain finance?
This is where a supplier who has submitted an invoice can be paid by a third-party finance provider earlier than the agreed payment date. The business would then pay the finance provider the invoiced sum.
❌
Under its payment practices and policies, can this business deduct sums from payments under qualifying contracts as a charge for remaining on a supplier list?
❌
During the reporting period, did the business deduct sums from payments as a charge for remaining on a supplier list?
No information available
Company Summary
GENOME RESEARCH LIMITED is an active private company established to undertake activities related to genome research
Its structure as a company limited by guarantee without share capital indicates that it operates without shareholders, with the liability of its members limited by their guarantee
The company was incorporated on 20 August 1992 and remains active under company number 02742969
Its registered office is located at Wellcome Sanger Institute Wellcome Genome Campus, Hinxton, Saffron Walden, England, CB10 1SA, placing its operations within the East of England
In the UK market, organisations structured as companies limited by guarantee without share capital typically focus on delivering specific services or public benefits rather than distributing profits to shareholders
For a company engaged in genome research, this could involve conducting scientific studies, publishing findings, providing expert consultation, or facilitating collaborative research projects within the field of genomics
